SomaLogic Press Release

WHAT: SomaLogic’s Healthcare Forum brings together local and national subject experts who are at the forefront of solutions that can deliver healthcare in a better, more fair and economical way. Speakers and panelists will discuss current healthcare delivery problems and potential solutions with an audience of 250 Coloradans.

WHY: In Colorado today, we face a healthcare crisis shared across the nation. While the United States spends more money on healthcare than any other country, the quality of our system is inferior. Patients and providers can benefit from new ideas, reform and emerging technologies that can change the status quo.

WHEN: Wednesday, April 13, 6-7:30 p.m.; reception from 5:30-6 p.m.

WHERE: University of Colorado, Boulder; Room A2B70 at the Department of Molecular, Cellular & Developmental Biology (MCDB) Building; Colorado Ave. on the CU campus (across from Folsom Stadium west entrance and adjacent to Balch Fieldhouse); paid parking in lot or meters on Colorado Ave.

WHO: Governor Richard Lamm, former governor of Colorado, director of the University of Denver’s Center for Public Policy and Contemporary Issues and author of The Brave New World of Health Care, will discuss “Infinite Needs vs. Finite Resources” to spark discussion regarding healthcare access and affordability.

Dr. David Lawrence, former CEO and Chariman of Kaiser Permanente and author of From Chaos to Care: The Promise of Team Based Medicine, will propose solutions including applying manufacturing models to healthcare management and other ideas gained from his extensive experience.

Dr. Grant Bagley, a partner in Arnold and Porter LLP’s life sciences practice out of Washington, D.C., Dr. Richard Byyny, executive director, Center for Health Policy, University of Colorado Hospital and Dr. Marilyn Coors, assistant professor at the Center for Bioethics and Humanities at the University of Colorado Health Science Center, will offer perspectives on health policy, legislation and ethics. Dr. Larry Gold, CEO and chairman of the board of SomaLogic, will provide introductions, and Dr. Elizabeth “Betsy” Hoffman, president of the University of Colorado System, will moderate the panel and audience discussion.

HOW: Admission is free, however, seating is limited and reservations are required by calling 303-625-9003 or sending an email to HealthcareForum@somalogic.com.

Additional sponsorship provided by Arnold and Porter LLP and the University of Colorado.

Contact:
SomaLogic
Beth Perez
303-625-2085
pr-ir@somalogic.com

About SomaLogic
SomaLogic is developing proteomics systems and applications based on its proprietary aptamer technology. The company's aptamer arrays will allow researchers--and ultimately clinicians--to measure large numbers of proteins simultaneously, providing the foundation for new insights into disease and health. SomaLogic is headquartered in Boulder, Colorado. Further information about the company can be found at http://www.somalogic.com. m.

Except for the historical information contained herein, this news release contains forward-looking statements that involve risks and uncertainties. Such forward-looking statements include SomaLogic's prospects for favorable growth and performance. The statements made by SomaLogic, Inc. are based on management's present expectations and actual results may differ from the results indicated or otherwise implied by such forward-looking statements due to certain risks and uncertainties including, but not limited to, our ability to secure funding to execute our business plan, our ability to gain market share by establishing the effectiveness of our products, the intense competition in research proteomics and commercial diagnostics, and general industry or business trends or events. These risk factors may not be an all-inclusive enumeration of the business risks faced by SomaLogic, Inc. These statements made by the management of SomaLogic, Inc. and summarized above represent their views as of the date of this press release, and it should not be assumed that the statements made herein remain accurate as of any future date. SomaLogic, Inc. does not presently intend to update these statements and undertakes no duty to any person to effect any such update under any circumstances.